Skip to Content
INVO Bioscience to Present at Tribe Public Event on April 13, 2021
INVO Bioscience Reports 2020 Financial Results
INVO Bioscience to Present at the Lytham Partners Spring 2021 Investor Conference
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021
Thinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean?
INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United States
INVO Bioscience to Participate in the 33rd Annual Roth Conference
Thinking about buying stock in Altimmune, Invo Bioscience, Norwegian Cruise Line, ADC Therapeutics, or Clovis Oncology?
INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U.S. Commercialization Agreement
INVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico